GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, firstname.lastname@example.org
Index / US Biomax / Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin / Product Detail : BRC962 Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
#BRC962 Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
Product name : Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
Catalog number : BRC962
Supplier name : US Biomax
Data sheet: Ask more or other datasheet now !
About this Product :Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin antibody storage GENTAUR recommends for long therm storage to freeze at -24 C. For short time storage up to 30 days we suggest fridge storage at 1 to 10 C. Prevent multiple freeze taw cycles of Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin.
Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin storing antibdies for longer storage periods of the Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin we recommend - 21C or lower and for short periods lees than 1 month we suggest +5C fridge temperatures.
More Details about
|Microarray Panel:||Breast cancer tissue microarray, including 36 cases of breast cancers and 12 cases of normal, reactive and benign tumor tissues of the breast in duplicates|
|Layout:||12 cols × 8 rows|
|Core Diameter:||1.5 mm|
|Quality Control:||H&E, IHC anti-Cytokeratin|
|Applications:||Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.|
|Notes:||Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.|
*Tissue Microarray Slide Types:
- Unstained: unstained paraffin tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Contact us about this product :
Our team will respond you as soon as possible !
We have also other products like : Breast cancer and normal tissue array, non-overlapping with BRC961, with TNM data, 48 cases_96 cores; ihc H&E, IHC anti-Cytokeratin
52062 Aachen Deutschland
Support Karolina Elandt
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
email@example.com | Gentaur
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Finland Helsset +358942419041
Magyarország Budapest +3619980547
US New York+17185132983
WP1984: Integrated Breast Cancer Pathway
WP1963: The effect of Glucocorticoids on target gene expression
WP1968: genetic alternations of lung cancer
WP2256: Integrated Pancreatic Cancer Pathway
WP2263: Prostate Cancer
WP2291: Deregulation of Rab and Rab Effector Genes in Bladder Cancer
WP2361: Gastric cancer network 1
WP2363: Gastric cancer network 2
WP2377: Integrated Pancreatic Cancer Pathway
WP1000: Arachidonate Epoxygenase Epoxide Hydrolase
WP1001: Peptide GPCRs
WP1002: Electron Transport Chain
WP1003: Ovarian Infertility Genes
WP1004: Kit Receptor Signaling Pathway
WP1005: GPCRs, Class B Secretin-like
WP1009: MAPK Cascade
WP1010: Wnt Signaling Pathway and Pluripotency
WP1011: T Cell Receptor Signaling Pathway
WP1017: Type II interferon signaling (IFNG)
WP1020: Fatty Acid Biosynthesis
WP1021: Phase I, non P450
WP1023: mRNA processing
WP1025: B Cell Receptor Signaling Pathway
WP1027: Glycolysis and Gluconeogenesis
WP1030: Selenium metabolism Selenoproteins
Related Genes :
[BRCA1 RNF53] Breast cancer type 1 susceptibility protein (EC 22.214.171.124) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1)
[BRCA2 FACD FANCD1] Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein)
[TP53 P53] Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53)
[MUC1 PUM] Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)]
[NRG1 GGF HGL HRGA NDF SMDF] Pro-neuregulin-1, membrane-bound isoform (Pro-NRG1) [Cleaved into: Neuregulin-1 (Acetylcholine receptor-inducing activity) (ARIA) (Breast cancer cell differentiation factor p45) (Glial growth factor) (Heregulin) (HRG) (Neu differentiation factor) (Sensory and motor neuron-derived factor)]
[AURKA AIK AIRK1 ARK1 AURA AYK1 BTAK IAK1 STK15 STK6] Aurora kinase A (EC 126.96.36.199) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A)
[PTK6 BRK] Protein-tyrosine kinase 6 (EC 188.8.131.52) (Breast tumor kinase) (Tyrosine-protein kinase BRK)
[AKT1 PKB RAC] RAC-alpha serine/threonine-protein kinase (EC 184.108.40.206) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha)
[PRPF31 PRP31] U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein) (Protein 61K) (hPrp31)
[BCAR1 CAS CASS1 CRKAS] Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas)
[AR DHTR NR3C4] Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4)
[NCOA3 AIB1 BHLHE42 RAC3 TRAM1] Nuclear receptor coactivator 3 (NCoA-3) (EC 220.127.116.11) (ACTR) (Amplified in breast cancer 1 protein) (AIB-1) (CBP-interacting protein) (pCIP) (Class E basic helix-loop-helix protein 42) (bHLHe42) (Receptor-associated coactivator 3) (RAC-3) (Steroid receptor coactivator protein 3) (SRC-3) (Thyroid hormone receptor activator molecule 1) (TRAM-1)
[CCAR2 DBC1 KIAA1967] Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (NET35) (p30 DBC)
[ABCG2 ABCP BCRP BCRP1 MXR] ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338)
[CHEK2 CDS1 CHK2 RAD53] Serine/threonine-protein kinase Chk2 (EC 18.104.22.168) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2)
[Brca2 Fancd1] Breast cancer type 2 susceptibility protein homolog (Fanconi anemia group D1 protein homolog)
[ESR1 ESR NR3A1] Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1)
[PTEN MMAC1 TEP1] Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 22.214.171.124) (EC 126.96.36.199) (EC 188.8.131.52) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)
[AKAP13 BRX HT31 LBC] A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47)
[Brca1] Breast cancer type 1 susceptibility protein homolog (EC 184.108.40.206) (RING-type E3 ubiquitin transferase BRCA1)
[TTN] Titin (EC 220.127.116.11) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14)
[NCOA6 AIB3 KIAA0181 RAP250 TRBP] Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (PRIP) (Thyroid hormone receptor-binding protein)
[BCAS3] Breast carcinoma-amplified sequence 3 (GAOB1)
[CHMP2A BC2 CHMP2] Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1) (Vps2-1) (hVps2-1)
[SGO1 SGOL1] Shugoshin 1 (Serologically defined breast cancer antigen NY-BR-85) (Shugoshin-like 1)
[EGFR ERBB ERBB1 HER1] Epidermal growth factor receptor (EC 18.104.22.168) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
[ATM] Serine-protein kinase ATM (EC 22.214.171.124) (Ataxia telangiectasia mutated) (A-T mutated)
[PSMD6 KIAA0107 PFAAP4] 26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regulatory particle subunit p44S10) (p42A)
[XBP1 TREB5 XBP2] X-box-binding protein 1 (XBP-1) (Tax-responsive element-binding protein 5) (TREB-5) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]
[SIRT1 SIR2L1] NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)]
 Differential Establishment of Bifidobacteria in the Breastfed Infant Gut.
 PD-1/PD-L1 Pathway in Breast Cancer.
 Breast Cancer-Related Lymphedema: Differentiating Fat from Fluid Using Magnetic Resonance Imaging Segmentation.
 Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer.
 Analgesic Effect of Maternal Human Milk Odor on Premature Neonates.
 Patient-Reported Outcomes 1 Year After Immediate Breast Reconstruction: Results of the Mastectomy Reconstruction Outcomes Consortium Study.
 d-Fructose Modification Enhanced Internalization of Mixed Micelles in Breast Cancer Cells via GLUT5 Transporters.
 Simultaneous determination of 4-hydroxyphenyl lactic acid, 4-hydroxyphenyl acetic acid, and 3-4-hydroxyphenyl propionic acid in human urine by Ultra high performance liquid chromatography with fluorescence detection.
 ITADE flap after mastectomy for locally advanced breast cancer: A good choice for mid-sized defects of the chest wall, based on a systematic review of thoracoabdominal flaps.
 Effects of Catechins and Their Related Compounds on Cellular Accumulation and Efflux Transport of Mitoxantrone in Caco-2 Cell Monolayers.
Enter catalog number :